BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35053594)

  • 1. Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation.
    Cellini F; Manfrida S; Casà C; Romano A; Arcelli A; Zamagni A; De Luca V; Colloca GF; D'Aviero A; Fuccio L; Lancellotta V; Tagliaferri L; Boldrini L; Mattiucci GC; Gambacorta MA; Morganti AG; Valentini V
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines.
    Cellini F; Arcelli A; Simoni N; Caravatta L; Buwenge M; Calabrese A; Brunetti O; Genovesi D; Mazzarotto R; Deodato F; Mattiucci GC; Silvestris N; Valentini V; Morganti AG
    Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival.
    Lancellotta V; Cellini F; Fionda B; De Sanctis V; Vidali C; Fusco V; Barbera F; Gambacorta MA; Corvò R; Magrini SM; Tagliaferri L
    Brachytherapy; 2020; 19(1):104-110. PubMed ID: 31636025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy for prostate cancer: What's the best in 2021.
    Cellini F; Tagliaferri L; Frascino V; Alitto AR; Fionda B; Boldrini L; Romano A; Casà C; Catucci F; Mattiucci GC; Valentini V
    Urologia; 2022 Feb; 89(1):5-15. PubMed ID: 34496707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal cancer management controversies: Radiation oncology point of view.
    Tai P; Yu E
    World J Gastrointest Oncol; 2014 Aug; 6(8):263-74. PubMed ID: 25132924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal stenting and radiotherapy: a multimodal approach for the palliation of symptomatic malignant dysphagia.
    Rueth NM; Shaw D; D'Cunha J; Cho C; Maddaus MA; Andrade RS
    Ann Surg Oncol; 2012 Dec; 19(13):4223-8. PubMed ID: 22752374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of radiotherapy in the multimodal management of esophageal cancer.
    Fokas E; Weiss C; Rödel C
    Dig Dis; 2013; 31(1):30-7. PubMed ID: 23797120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative Treatment of Esophageal Cancer.
    Ahmad NR; Goosenberg EB; Frucht H; Coia LR
    Semin Radiat Oncol; 1994 Jul; 4(3):202-214. PubMed ID: 10717108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO).
    Iwai Y; Nemoto MW; Horikoshi T; Kanazawa A; Kurokawa M; Saito M; Harada R; Kobayashi H; Uno T
    Jpn J Radiol; 2020 Sep; 38(9):899-905. PubMed ID: 32333219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Radiotherapy in Localized Esophageal and Gastric Cancer.
    Ng J; Lee P
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):453-468. PubMed ID: 28501087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
    Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
    Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in palliative therapy.
    Siersema PD
    Best Pract Res Clin Gastroenterol; 2006; 20(5):959-78. PubMed ID: 16997172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy of esophageal cancer.
    Hancock SL; Glatstein E
    Semin Oncol; 1984 Jun; 11(2):144-58. PubMed ID: 6203175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy.
    Boekhoff MR; Defize IL; Borggreve AS; Takahashi N; van Lier ALHMW; Ruurda JP; van Hillegersberg R; Lagendijk JJW; Mook S; Meijer GJ
    Radiother Oncol; 2020 Jun; 147():1-7. PubMed ID: 32234611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TU-E-213CD-01: Image Guided Adaptive Brachytherapy for Cervical Cancer.
    Craciunescu O; Cai J; de Leeuw A; Kirisits C
    Med Phys; 2012 Jun; 39(6Part24):3913. PubMed ID: 28518703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
    Xu Y; Yu X; Chen Q; Mao W
    World J Surg Oncol; 2012 Aug; 10():173. PubMed ID: 22920951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
    Specht L; Yahalom J; Illidge T; Berthelsen AK; Constine LS; Eich HT; Girinsky T; Hoppe RT; Mauch P; Mikhaeel NG; Ng A;
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):854-62. PubMed ID: 23790512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
    Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
    Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.